Pediatric Endocrine department - Trousseau Hospital
Paris, 75012, France
Location contact
Irène Netchine, PUPH - MD, PhD
CONTACT
Marie-Pierre Luton, PhD
CONTACT
NCT Number: NCT06878716
Silver Russell Syndrome (SRS) is a rare imprinting disorder (about 1/16000). Parental imprinting is an epigenetic regulation phenomenon leading to the monoallelic expression of some genes. Its establishment takes place in the gametes and its maintenance is important at the early embryonic stage. Increase in the prevalence of conception by assisted reproductive technology (ART) has already been found in patients with imprinted disorder such as Angelman, Beckwith-Wiedemann or Prader Willi Syndromes, and more recently with SRS; ART is associated with an increase in the frequency of SRS. Several hypotheses are formulated to explain this increase. The first one is the involvement of the infertility etiology in the imprinting disorder genesis. The second one is the involvement of ART technics in the genesis of abnormal gamete imprinting during their manipulation or during imprinting maintenance at early embryonic stages.
Our main objective is to estimate ART conceptions prevalence in children followed for a SRS. The secondary objectives are to estimate infertility prevalence among parents of patients with SRS, to estimate factors frequency possibly responsible for the genesis of imprinting anomalies among parents of patients with SRS, to describe the infertility causes and to detail ART technics used (stimulation protocols, type of fertilization used, modality of embryonic culture and transfer, embryonic characteristics).
A transversal pilote study will be firstly conducted in parents of patients followed in Silver Russell Syndrome Reference Center (Pediatric Endocrine department, in Trousseau Hospital, Paris).
Data collection will be done by phone, after collecting the non-opposition of the parents, in order to complete a questionnaire concerning their fertility and conception mode of their child. If ART was used to conceive, a questionnaire concerning the details of the ART technics used will be sent to the doctor and:or the ART biologist, who performed the ART. The data will be anonymized and collected on a REDCap database.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Paris, 75012, France
Irène Netchine, PUPH - MD, PhD
CONTACT
Marie-Pierre Luton, PhD
CONTACT
There is no planned follow-up, and the parents' participation is limited to the telephone interview.
The aim is to conduct / carry out a single-centre observational cross-sectional study, on the one hand by collecting data from the centre's patient files (molecular anomaly leading to the diagnosis of Silver Russell syndrome) and on the other hand by conducting a 30-minute telephone questionnaire to collect additional data. The first part of this questionnaire will be carried out with the parents of these patients in order to specify their age, height, weight, drug consumption and profession at the time of the start of pregnancy, as well as the time required for conception and recourse to ART.
In the event of recourse to ART, with the authorisation of the parent(s), a questionnaire will be sent to the clinical doctor and/or the biologist at the ART centre.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 0, visit inclusion
To estimate ART conceptions prevalence in children followed for a SRS
Time frame: Day 0, visit inclusion
The time required for conception is defined by the time between stopping contraception and the start of pregnancy
Time frame: Day 0, visit inclusion
Time frame: Day 0, visit inclusion
At the time of conception maternal and paternal BMI, consumption of tobacco and alcohol and both parents' occupations
Time frame: Day 0, visit inclusion
Time frame: 3 years, end of the study
Study infertility causes in detail this will be do through a questionnaire send to the fertility doctor who treated the parents.
Time frame: 3 years, end of the study
Details of ART techniques used this will be do through a questionnaire send to the fertility doctor who treated the parents.
Contact information is provided by the study sponsor or research team.
Irène Netchine, PUPH, MD, PhD
CONTACT
Marie-Pierre Luton, PhD
CONTACT
Assistance Publique - Hôpitaux de Paris
Other
Official Title : Silver Russell Syndrome, Parental Fertility and Assisted Reproductive Technology 600 caractères Maximum
Acronym: SRS-AMP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07738068
Female Infertility, Female Urogenital Diseases
View Trial DetailsNCT07736261
Genital Diseases, Infertility
Banhā, Qalyubia Governorate, Egypt
View Trial DetailsNCT07725458
Behavior, Genital Diseases
Tampa, Florida, United States
View Trial DetailsNCT07700602
Clinical Pregnancy After Single Embryo Transfer, Embryo Diagnosis and Selection
Ho Chi Minh City, Vietnam
View Trial Details